title: [The progress of chemotherapy for advanced pancreatic cancer].
authors.affiliation: Pancreatic Cancer Center, Osaka Medical Center for Cancer and Cardiovascular Diseases.
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Ioka
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Katayama
authors.forename: Reiko
authors.initials: R
authors.lastname: Ashida
authors.forename: Hidenori
authors.initials: H
authors.lastname: Takahashi
authors.forename: Teruki
authors.initials: T
authors.lastname: Teshima
authors.forename: Masato
authors.initials: M
authors.lastname: Sakon
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004338:Drug Combinations; D000069347:Erlotinib Hydrochloride / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D010094:Oxonic Acid / Q000627:therapeutic use; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D005641:Tegafur / Q000627:therapeutic use; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D004338:Drug Combinations; D009944:Organoplatinum Compounds; D003841:Deoxycytidine; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid; D000069347:Erlotinib Hydrochloride; D002955:Leucovorin; D005472:Fluorouracil; D000093542:Gemcitabine